Literature DB >> 20162610

Cancer incidence in a rural population of South Africa, 1998-2002.

Nontuthuzelo Im Somdyala1, Debbie Bradshaw, Wentzel Ca Gelderblom, Donald M Parkin.   

Abstract

Cancer incidence rates and patterns are reported for a rural population, living in the Eastern Cape Province of South Africa for the period 1998-2002. The population-based cancer registry has operated for 20 years, using both active and passive methods for case finding, through collaborations with 19 health facilities: 11 district hospitals, 7 referral hospitals and 1 regional laboratory. The age standardized incidence rates for all cancers were 73.1 per 100,000 in males and 64.1 per 100,000 in females. The leading top 5 cancers for males were oesophagus (32.7 per 100,000), lung (5.8 per 100,000), prostate (4.4 per 100,000), liver (4.4 per 100,000) and larynx (2.5 per 100,000) whereas for females they were cervix (21.7 per 100,000), oesophagus (20.2 per 100,000), breast (7.5 per 100,000), ovary (0.9 per 100,000) and liver (0.9 per 100,000). The incidence of Kaposi sarcoma was low, and higher for males (1.6 per 100,000) than females (0.3 per 100,000). Lung cancer in both males and females was relatively low compared to the high incidence of oesophagus cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20162610     DOI: 10.1002/ijc.25246

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

Review 1.  Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings.

Authors:  Aggrey S Semeere; Naftali Busakhala; Jeffrey N Martin
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

Review 2.  Appraising the quality of sub-Saharan African cancer registration systems that contributed to GLOBOCAN 2008: a review of the literature and critical appraisal.

Authors:  Tim Crocker-Buque; Allyson M Pollock
Journal:  J R Soc Med       Date:  2015-02       Impact factor: 5.344

Review 3.  Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.

Authors:  Vincent T Janmaat; Ewout W Steyerberg; Ate van der Gaast; Ron Hj Mathijssen; Marco J Bruno; Maikel P Peppelenbosch; Ernst J Kuipers; Manon Cw Spaander
Journal:  Cochrane Database Syst Rev       Date:  2017-11-28

4.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

5.  A phase III, multicenter randomized controlled trial of neo-adjuvant chemotherapy paclitaxel plus cisplatin versus surgery alone for stage IIA-IIIB esophageal squamous cell carcinoma.

Authors:  Yan Zheng; Yin Li; Xianben Liu; Ruixiang Zhang; Zongfei Wang; Haibo Sun; Shilei Liu
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

6.  Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa.

Authors:  Hannah Bye; Natalie J Prescott; Marco Matejcic; Elizabeth Rose; Cathryn M Lewis; M Iqbal Parker; Christopher G Mathew
Journal:  Carcinogenesis       Date:  2011-09-16       Impact factor: 4.944

7.  Improving Breast Cancer Control via the Use of Community Health Workers in South Africa: A Critical Review.

Authors:  Brianna M Wadler; Christine M Judge; Marianne Prout; Jennifer D Allen; Alan C Geller
Journal:  J Oncol       Date:  2010-09-26       Impact factor: 4.375

8.  Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.

Authors:  Julia Bohlius; Fabio Valeri; Mhairi Maskew; Hans Prozesky; Daniela Garone; Mazvita Sengayi; Matthew P Fox; Mary-Ann Davies; Matthias Egger
Journal:  Int J Cancer       Date:  2014-05-02       Impact factor: 7.396

9.  Distinct genetic association at the PLCE1 locus with oesophageal squamous cell carcinoma in the South African population.

Authors:  Hannah Bye; Natalie J Prescott; Cathryn M Lewis; Marco Matejcic; Loven Moodley; Barbara Robertson; Christo van Rensburg; M Iqbal Parker; Christopher G Mathew
Journal:  Carcinogenesis       Date:  2012-08-03       Impact factor: 4.944

10.  Neoadjuvant chemotherapy with or without neoadjuvant radiotherapy compared with neoadjuvant chemoradiotherapy for esophageal cancer.

Authors:  Yan Zheng; Xianben Liu; Ruixiang Zhang; Zongfei Wang; Haibo Sun; Jianjun Qin; Shilei Liu; Yin Li
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.